Patent details

92300 Product Name: Regorafenib et ses sels pharmaceutiquement acceptables (STIVARGA)

Basic Information

Publication number:
92300
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP047860911
Legal Status:
Active
Application number:
92300
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/13/858/001
Marketing Authorization Type:
Marketing Authorization Date:
29/08/2013
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
30/10/2013
First Marketing Authorization date:
29/08/2013
Grant date:
30/12/2013
Activation date:
22/07/2024
Publication date:
30/12/2013
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
29/08/2028
SPC Extension Expiration:
29/08/2028
Rejection date:
Withdrawal date:

Owner

From:
30/10/2013
 
 

Name:
BAYER HEALTHCARE LLC
Address:
BAYER BOULEVARD 100, WHIPPANY, NEW JERSEY 07981, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/10/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BOYER Stephen
Address:
Germany (DE)

2

Name:
WILHELM Scott
Address:
United States (US)

3

Name:
RIEDL Bernd
Address:
Germany (DE)

4

Name:
DUMAS Jacques
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
23
Annual Fee Amount:
430 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/07/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
15/02/2016 Incoming Correspondence (Post) 3
16/01/2019 Publication 1
16/01/2019 Outgoing Correspondence 1